Scholarlink

Abstract <p>The article examines prospective opportunities for implementing the <i>Pharma-2030</i> strategy aimed at the development of the pharmaceutical industry, providing a critical assessment of scenario forecasts and the growth potential of this sector. It is shown that the anticrisis policy implemented by the government in the pharmaceutical industry, in the context of increased sanctions pressure on Russia, ensured stabilization in the domestic market of medicines over 2022–2024. It is pointed out that some provisions of the <i>Pharma-2030</i> strategy require clarification in connection with new national goals in terms of ensuring technological independence and increasing the share of pharmaceutical products created based on proprietary development lines.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Analysis and Assessment of the Prospects for Implementing the Strategy for the Development of the Pharmaceutical Industry under External Constraints

  • 期刊论文

  • 发表日期：

    2025年9月8日

查看全文
  • V. V. Dorzhieva

摘要

Abstract

The article examines prospective opportunities for implementing the Pharma-2030 strategy aimed at the development of the pharmaceutical industry, providing a critical assessment of scenario forecasts and the growth potential of this sector. It is shown that the anticrisis policy implemented by the government in the pharmaceutical industry, in the context of increased sanctions pressure on Russia, ensured stabilization in the domestic market of medicines over 2022–2024. It is pointed out that some provisions of the Pharma-2030 strategy require clarification in connection with new national goals in terms of ensuring technological independence and increasing the share of pharmaceutical products created based on proprietary development lines.